cempra inc
(CEMP:NASDAQ SE Consolidated Large Cap)

Executive Profile*

Background*

Dr. Andrew N. Schiff, Drew, MD is a Managing Partner at Aisling Capital, Aisling Capital III, L.P. and Aisling Capital II, L.P. Dr. Schiff serves as the Managing Director of Perseus-Soros Biopharmaceutical Fund. In addition, Dr. Schiff is also a Partner of Kuhn, Loeb & Co. He joined Perseus-Soros Biopharmaceutical Fund, L.P. (Fund I) in September 1999 and has served as a Managing Partner since 2002. Since June 1990, he has practiced internal medicine at The New York ... Presbyterian Hospital, where he maintains his position as a Clinical Assistant Professor of Medicine. He has been a Director of Adams Laboratories, Inc. since 2001. Dr. Schiff serves as a Director of ARMGO Pharma, Inc., Visiting Nurse Service Of New York, Sirion Therapeutics Inc., Dynova Laboratories, Inc. and Henry Street Settlement. He has been a Director of Agile Therapeutics, Inc. since July 19, 2012. He has been a Director of Sirion Holdings, Inc. since April 2007, TransEnterix, Inc. since October 2009, Planet Biopharmaceuticals, Inc. since November 2007 and SkinMedica, Inc. since April 2004. He has been a Director of Zeltiq Aesthetics, Inc. since July 2010. He serves as a Board Observer at Cempra, Inc. He serves as a Director of Miramar Labs, Inc. He serves as Member of American Advisory Board Members at Christie's International SA, Christies International plc and Christie's Inc. He served as a Director of Barrier Therapeutics Inc. from May 2002 to July 14, 2005. Dr. Schiff served as a Director of Gilead Colorado, Inc. from December 2001 to March 11, 2005. He served as a Director of Zanett Inc. from October 2000 to September 2004. Dr. Schiff served as a Director of Bioenvision Inc. from May 2002 to July 13, 2007. Dr. Schiff served as a Director of Cardiokine Inc., ArgiNOx Pharmaceuticals, Inc., and Cempra Pharmaceuticals, Inc. He served as Director of Adams Respiratory Therapeutics, Inc. from 2001 to February 2007. He received an M.D. from Cornell University Medical College and an M.B.A. from Columbia University. Dr. Schiff also received a B.S. degree in Neuroscience, with honors, from the Brown University.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
CEMP:US	$7.13 USD	+0.25

COMPETITOR COMPENSATION